Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.770
-0.010 (-0.56%)
Jul 19, 2024, 4:30 PM EDT - Market closed
Biodesix Market Cap
Biodesix has a market cap or net worth of $202.99 million as of July 22, 2024. Its market cap has increased by 117.34% in one year.
Market Cap
202.99M
Enterprise Value
252.68M
1-Year Change
117.34%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on October 28, 2020, Biodesix's market cap has decreased from $472.57M to $202.99M, a decrease of -57.04%. That is a compound annual growth rate of -20.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 203.00M | 21.92% |
| Dec 29, 2023 | 166.50M | 72.00% |
| Dec 30, 2022 | 96.80M | -32.26% |
| Dec 31, 2021 | 142.90M | -73.29% |
| Dec 31, 2020 | 535.10M | 13.23% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 209.32M |
| Shattuck Labs | 209.22M |
| Caribou Biosciences | 207.28M |
| Genfit | 207.00M |
| Pyxis Oncology | 204.93M |
| bluebird bio | 202.38M |
| CVRx, Inc. | 202.13M |
| Outset Medical | 200.17M |